Physical Activity in the Management of Personality Disorders
PANDA
1 other identifier
interventional
60
1 country
2
Brief Summary
The PANDA trial is studying whether two types of physical activity - a walking program and supervised karate training - are safe, acceptable, and possible for adults with certain personality disorders. The goal is to see if these activities can help people while being safe and easy to do. Who can take part:
- Adults with borderline personality disorder or avoidant/anxious personality disorder.
- People receiving treatment at two outpatient mental health clinics in the Capital Region of Denmark.
- The study plans to include about 60 participants. What will happen in the study: Participants are randomly assigned to one of three groups:
- Usual treatment only (control group).
- Usual treatment plus walking program: an 8 - week pedometer - based program with goal setting and follow-up sessions.
- Usual treatment plus supervised karate training: an 8 - week program led by experienced instructors. What the study will look at:
- Main goal: Check if the programs can be done as planned, including whether participants attend sessions, follow the program, and stay safe.
- Other outcomes: Possible changes in physical health, fitness, emotions, personality symptoms, body image, and daily activity.
- Data will be collected through physical tests, questionnaires, and follow-up interviews about participants' experiences and motivation.
- Measurements will take place at the start, after 8 weeks, and after 12 weeks (follow-up questionnaires only). Why this study is important: The results will help researchers decide if it is possible to run a larger study in the future to see if walking or karate training can improve health and wellbeing for people with personality disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
January 14, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
February 3, 2026
February 1, 2026
9 months
December 12, 2025
February 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Referral rate (initial interest rate)
The proportion of patients approached by clinical staff who agree to be referred to the research team for further information about the study. Calculation: Number of patients referred to the research team/Number of patients approached by clinical staff.
Assessed continuously throughout the recruitment period.
Screening rate
The proportion of participants referred by clinical staff who complete the research team's information session. Calculation: Number of participants attending the information session/Number of participants referred by clinical staff.
Assessed continuously throughout the recruitment period, prior to each participant's baseline assessment.
Recruitment rate (consent rate)
The proportion of participants who consent to join the trial after attending the research team's information session. Calculation: Number of participants providing informed consent/Number of participants attending the information session.
Assessed continuously throughout the recruitment period.
Retention rate
The proportion of participants who remain in the trial until completion. Calculation: Number of participants completing the study/Number of participants initially enrolled.
From each participant's baseline assessment (week 0) to their 12-week follow-up.
Adherence
The extent to which participants comply with their assigned intervention. Individual criteria: Karate group: Attendance at ≥8 of 16 sessions (≥50%). Walking group: Achievement of individually defined weekly step goals in ≥6 of 8 weeks (≈70%). Progression criterion: Progression to a full-scale RCT without modification requires that at least 70% of participants in each intervention arm meet these adherence criteria.
Assessed during the 8-week intervention period for each participant.
Safety (Adverse Events)
Occurrence of any adverse events (AEs) during the intervention period. Assessment: Bi-weekly self-reported electronic questionnaires via REDCap. Extraction from medical records for events such as emergency department visits.
Weeks 0-8 for the intervention period for each participant; medical record review extend through 12-week follow-up.
Reasons for non-participation or drop-out
Documented explanations provided voluntarily by participants who decline participation or discontinue the trial. Assessment: Categorized according to predefined options (e.g., intervention not attractive, inconvenient timing, travel distance, lack of energy, other).
Collected throughout recruitment and study participation for each individual (from invitation to 12-week follow-up).
Secondary Outcomes (13)
Simple Physical Activity Questionnaire (SIMPAQ)
Baseline and 8-weeks follow-up.
Exercise Addiction Inventory (EAI)
Baseline, 8 weeks, and 12 weeks follow-up.
Body composition
Baseline and at 8-weeks follow-up.
Personality Disorder Severity Scale - ICD 11 (PDS ICD 11)
Baseline, 8 weeks, and 12 weeks follow up.
Inventory of Interpersonal Problems - 32 items (IIP 32)
Baseline, 8 weeks, and 12 weeks follow up.
- +8 more secondary outcomes
Study Arms (3)
Treatment as usual
ACTIVE COMPARATORParticipants in this arm receive treatment as usual and function as the control group.
Karate
EXPERIMENTALParticipants receive supervised karate training twice a week for 8 weeks from experienced instructors.
Walking
EXPERIMENTALParticipants follow an 8-week pedometer-based walking program with individually tailored goals.
Interventions
The karate group will be offered an 8-week, group-based Shotokan Karate-Do program with two 1-hour sessions per week, delivered at a local karate club. Sessions will be led by two experienced instructors who has recieved lectures in relevant personality pathology and treatment principles. The instructors will plan and adapt the training, which includes meditation to promote focus and calm, Kihon (basic techniques) to practice fundamental movements, Kumite (partnered exercises) to develop coordination, collaboration, and controlled sparring skills, and stretching to support recovery and flexibility. Exercises will be tailored individually to participants' needs, addressing both physical and cognitive aspects of training. Participants will receive relevant equipment, such as a karate uniform and participants may continue attending classes after the 8-week intervention until the end of the study.
Treatment as usual comprise treatment as usual within the psychiatric services. Participants are engaged in ongoing psychotherapeutic treatment when referred to the PANDA study, which includes group and/or individual therapy. As part of the group allocation information, they will be informed about the official Danish physical activity guidelines. Participants will be encouraged to continue their usual daily activities without any specific guidance toward or restriction from engaging in other interventions.
The pedometer-based walking group include a pedometer (Garmin VivoFit 4) and a walking diary, inspired by NICE guidance (PH41). Materials will be reviewed with each participant to ensure understanding and support individual goal-setting. Goals will be tailored to each participant, aiming either to gradually increase daily PA or to establish a structured and manageable activity routine, depending on individual needs and preferences. The diary encourages daily step recording and reflection on physical activity habits. Throughout the 8-week intervention, participants will receive regular check-ins by phone or online at weeks 2, 4, and 6 to review progress, provide structured feedback, and adjust goals as needed.
Eligibility Criteria
You may qualify if:
- adults (≥18 years)
- documented diagnosis of borderline personality disorder (BPD; F60.3, ICD-10) or avoidant personality disorder (AVPD; F60.6, ICD-10), as confirmed in the patient's medical record.
- at the time of recruitment, participants must be receiving treatment at one of two specialized psychotherapeutic outpatient clinics (Clinic A or Clinic B) in the Capital Region of Denmark
- proficient in Danish.
You may not qualify if:
- Individuals with a documented diagnosis of antisocial personality disorder (F60.2)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Julie Midtgaardlead
- Danish Council for Independent Researchcollaborator
- Helsefonden, Denmarkcollaborator
Study Sites (2)
Mental Health Center Stolpegård, Copenhagen University Hospital -Mental Health Services CPH, Copenhagen Denmark
Gentofte Municipality, Capital Region, 2820, Denmark
Mental Health Centre Glostrup, Copenhagen University Hospital - Amager and Hvidovre, Denmark
Glostrup Municipality, Capital Region, 2620, Denmark
Related Publications (1)
Petersen J, Palic S, Nyboe L, Schuster M, Videbech P, Midtgaard J. Physical activity in the management of borderline personality disorder: A scoping review. Psychiatry Res. 2025 Aug;350:116535. doi: 10.1016/j.psychres.2025.116535. Epub 2025 May 5.
PMID: 40398190BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie Midtgaard, Professor
Copenhagen University Hospital - Amager and Hvidovre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 12, 2025
First Posted
January 14, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
February 3, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share
Individual participant data cannot be shared publicly due to ethical constraints; however, qualified researchers may submit individual requests for access.